Fei Chen

Fei Chen, Ph.D., is a Managing Partner with Lilly Asia Ventures (LAV). Prior to joining LAV in 2009, when LAV was corporate venture arm of Eli Lilly and Co., Fei worked at The Balloch Group, a leading boutique investment banking firm in China, where he provided financial advisory services for local pharmaceutical companies in private placement and cross-border M&A transactions. Fei holds a Ph.D. in molecular genetics and a Bachelor’s degree in biology from Fudan University.